Michael Sardano, PRESIDENT AND GENERAL COUNSEL at Sensus Healthcare, Inc. (SRTS), bought 2,000 shares at $4.34 ($9K) on 2025-11-11, disclosed to the SEC on 2025-11-18.
Open-market purchase of $9k SRTS by PRESIDENT AND GENERAL COUNSEL. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.26 | 1,000 | $4K | 49.8% |
| 2 | $4.27 | 766 | $3K | 38.3% |
| 3 | $4.34 | 234 | $1K | 11.9% |
| Total | $4.27 avg | 2,000 | $9K | 100% |
| Filing → |
| SRTS | BUY | 2025-08-14 | $3K | — | Filing → |
| SRTS | BUY | 2025-02-10 | $6K | — | Filing → |
| SRTS | BUY | 2023-08-28 | $3K | — | Filing → |